Through the power of the IQVIA CORE, our clinical trial experts can bypass the low performers and instead prioritize the top potential recruiters -- speeding enrollment and your study completion. To validate this approach, we put it to the test against the universe of our >500 ongoing clinical studies. See the impact based on actual enrollment rates below.
In traditional clinical trials, sites are selected based on experience and relationships – with less than stellar results. IQVIA has developed a more precise way to predict the best-performing sites and investigators. This approach integrates
IQVIA has alliances with investigators in clinics and hospitals of every size, linked to prime and partner sites worldwide. This global reach lets us identify the right patients - and engage the right sites - to go from insight to action.
Assess your protocol against real world evidence using advanced analytics, and reduce the risk of costly amendments.
Leverage a global network of Phase I clinical pharmacology units to build diversity in patient populations and access a range of geographic regions for early clinical development (ECD) programs.
Improve the performance of your clinical trials with the power of the IQVIA CORE.
Predict enrollment more accurately and increase the number of patients per site using data-driven patient recruitment solutions.
Access central labs around the globe through Q2 Solutions, a joint venture between IQVIA and Quest Diagnostics.